Key facts
- Aevice Health’s last known valuation is $28.3M (Dec 2024).
- It has raised $11.3M; the latest was Later Stage VC in Jan 2025.
- Notable investors include MassChallenge, MedTech Innovator, East Ventures, Texas Medical Center, Pegasus Tech Ventures — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Aevice Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Aevice Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aevice Health
Developer of a chronic respiratory wellness device designed for asthmatic patients. The company's device records important and relevant historical data regarding respiratory symptoms and medication intake to facilitate the early detection of cardiopulmonary abnormalities remotely and in real-time, enabling patients to receive fast and targeted care from the ease of their homes.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2016
- Employees
- 12
- Website
- aevice.com/
- Ownership
- Privately Held (backing)
Aevice Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aevice Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aevice Health in its N-PORT filings yet. We sweep new filings monthly.